Press Release Tech Versuni launches new Philips Home Safety 5000 series featuring world-first sensing technology The Philips Home Safety range includes a wireless sensing system comprising of… CISION PRNewswireJanuary 9, 2024
Press Release Tech Queclink's Cutting-Edge Vehicle Tracker Puts Automobile Insurance and UBI Telematics on the Fast Track SHANGHAI, Jan. 9, 2024 /PRNewswire/ — Queclink, the world-leading IoT device and… CISION PRNewswireJanuary 9, 2024
Press Release Eye Level Thailand's CSR Scholarships: Redefining Education with Social Responsibility BANGKOK, Jan. 9, 2024 /PRNewswire/ — Embarking on a journey to redefine… CISION PRNewswireJanuary 9, 2024
Press Release Thunes expands its leadership to accelerate growth Floris de Kort appointed CEO Peter De Caluwe promoted to Deputy Chairman… CISION PRNewswireJanuary 9, 2024
Banking Press Release Mirae Asset Announces Fee Reduction for Global X USD Money Market ETF to Benefit Investors HONG KONG, Jan. 9, 2024 /PRNewswire/ — Mirae Asset Global Investments (Hong… CISION PRNewswireJanuary 9, 2024
Press Release Abbisko Therapeutic announces that EMA has granted orphan drug designation for its CSF-1R inhibitor Pimicotinib （ABSK021） SHANGHAI, Jan. 9, 2024 /PRNewswire/ — On January 9, 2024 (Beijing Time),… CISION PRNewswireJanuary 9, 2024
Business Lifestyle Press Release Innovent Announces the First Phase 3 Clinical Trial of Mazdutide in Chinese Adults with Overweight or Obesity Met the Primary and All Key Secondary Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA ROCKVILLE, Md. and SUZHOU, China, Jan. 9, 2024 /PRNewswire/ — Innovent Biologics,… CISION PRNewswireJanuary 9, 2024
Press Release Tech Chemical.AI partners with NTU Singapore to advance automated and AI-powered research platform for nanomaterials SINGAPORE, Jan. 9, 2024 /PRNewswire/ — Chemical.AI recently announced a partnership with Nanyang… CISION PRNewswireJanuary 9, 2024
